| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.002 |